Home | Clinical Care | Research | Training | Division Activities

Education and Training:

B.S., University of Kansas, Lawrence, KS (1978)

M.D., University of Kansas, Kansas City, KS (1982)

Internship/Residency, Department of Medicine, Rhode Island Hospital, Providence, RI (1982-85)

Fellowship, Department of Medicine, Division of Hematology, University of Washington, Seattle, WA (1986-89)

Michael L. Linenberger, M.D., F.A.C.P.
Professor of Medicine
Division of Hematology
Associate Program Director, Hematology/Oncology Fellowship
University of Washington School of Medicine

Medical Director, Apheresis and Cellular Therapy,
Seattle Cancer Care Alliance
Associate Member,
Fred Hutchinson Cancer Research Center

Office Address:
Seattle Cancer Care Alliance
Box 358081, FHCRC Mailstop G4940
825 Eastlake Ave. E.
Seattle, WA 98109

Phone:   (206) 288-2038
Fax:       (206) 288-2000
E-mail:   linen@u.washington.edu


CURRENT CLINICAL INTERESTS

Hematologic malignancies, benign hematologic disorders, bleeding and thrombotic disorders, therapeutic apheresis and stem cell procurement


CURRENT RESEARCH INTERESTS

Extracorporeal photochemotherapy for pediatric graft-versus-host disease and safety of peripheral blood stem cell mobilization and collection in elderly donors


SELECTED PUBLICATIONS

Linenberger ML and Price TH:  Use of cellular and plasma apheresis in the critically ill patient. Part I: Technical and physiological considerations. J. Intensive Care Medicine 20:18-27, 2005.

Linenberger ML:  CD33-directed therapy with gemtuzumab ozogamicin in acute myeloid leukemia: progress in understanding cytotoxicity and potential mechanisms of resistance. Leukemia 19:176-182, 2005.

Linenberger ML and Price TH:  Use of cellular and plasma apheresis in the critically ill patient. Part II: Clinical indications and applications. J. Intensive Care Medicine 20:88-103, 2005.

Linenberger ML and Wittkowski, A.K. Thromboembolic complications of malignancy: Part 1. Risks. Oncology 19:853-861, 2005.

Linenberger ML and Wittkowski, A.K. Thromboembolic complications of malignancy: Part 2. Management. Oncology 19:1077-1084, 2005.

Linenberger M:  Catheter-related thrombosis: risks, diagnosis and management.  J. Natl. Canc Netw 4:889-901, 2006.

Nester T, and Linemberger M:  Therapeutic apheresis: technical considerations and medications in critical care.  In: Intensive Care Medicine, 6th ed., Richard S. Irwin and James M. Rippe (eds), Lippincott Williams & Wilkins, 2008.